Cart
sales@molnova.com
Rotenolone
CAS No. 509-96-6
Rotenolone( Rotenolone I | 12alpha-HYDROXYROTENONE )
Catalog No. M28011 CAS No. 509-96-6
Rotenolone is a metabolite of Rotenone which is a natural compound derived from plants of the genera Derris and Lonchocarpus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 297 | In Stock |
|
| 10MG | 446 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRotenolone
-
NoteResearch use only, not for human use.
-
Brief DescriptionRotenolone is a metabolite of Rotenone which is a natural compound derived from plants of the genera Derris and Lonchocarpus.
-
DescriptionRotenolone is a metabolite of Rotenone which is a natural compound derived from plants of the genera Derris and Lonchocarpus.
-
In Vitro——
-
In Vivo——
-
SynonymsRotenolone I | 12alpha-HYDROXYROTENONE
-
PathwayOthers
-
TargetOther Targets
-
Recptoradenylyl cyclase 1(AC1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number509-96-6
-
Formula Weight410.422
-
Molecular FormulaC23H22O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12COc3cc(OC)c(OC)cc3[C@@]1(O)C(=O)c1ccc3O[C@H](Cc3c1O2)C(C)=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.1. Scott JA, et al. Optimization of a Pyrimidinone Series for Selective Inhibition of Ca2+/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic Pain. J Med Chem. 2022; 65(6):4667-4686.
molnova catalog
related products
-
3-?O-?Acetylhamaudol
3'-?O-?Acetylhamaudol, isolated from the roots of Angelica japonica, exhibits anti-tumor activity through dual actions, anti-angiogenesis and intestinal intraepithelial lymphocyte activation.
-
Thymosin β4 (human, ...
Thymosin β4 (human, bovine, horse, rat)
-
G-Protein antagonist...
Substance P-related peptide that inhibits binding of G proteins to their receptors. Competitively and reversibly inhibits M2 muscarinic receptor activation of Gi or Go and inhibits Gs activation by β-adrenoceptors.
